Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    24434094 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Customized Adherence Enhancement Plus Long-acting Injectable Antipsychotic
Condition: Patient Noncompliance
Interventions: Drug: haloperidol decanoate;   Drug: haloperidol;   Behavioral: Customized  Adherence Enhancement

Indicates status has not been verified in more than two years